Back

JPMorgan expects more Indian overseas M&A as outbound deals near $24 billion

Verifying
  • JPMorgan expects Indian companies to pursue more overseas mergers and acquisitions.
  • $24 billion: Indian outbound deals are approaching a record high this year.
  • Sun Pharmaceutical's $11.75 billion Organon acquisition is expected to close in early 2027.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.